Eastern and Central European perspectives in potentially inappropriate medication use and polypharmacy in older patients (EU COST initiative IS 1402)
Abstract
The conference contribution describes the situation in EU countries related to registration rates of potentially inappropriate medications, particularly in the Czech Republic, Serbia, Hungary, Portugal, Spain and Turkey